Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 20001-20050 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02088554
PERIGON Pivotal Trial
NA
Active, not recruiting
1,312 participants
Started: May 12, 2014 · Completed: Dec 31, 2035
1 condition
2 sponsors
38 locations
NCT02094794
Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML
PHASE2
Active, not recruiting
108 participants
Started: May 12, 2014 · Completed: May 26, 2026
10 conditions
2 sponsors
1 location
NCT03604406
The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept
PHASE2
Active, not recruiting
154 participants
Started: May 8, 2014 · Completed: Feb 28, 2026
3 conditions
3 sponsors
5 locations
NCT02125786
A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
PHASE2
Active, not recruiting
68 participants
Started: May 7, 2014 · Completed: May 31, 2028
1 condition
1 sponsor
1 location
NCT03199196
Using Social Networks to Promote Physical Activity in African American and Hispanic Women
NA
Active, not recruiting
101 participants
Started: May 2, 2014 · Completed: May 30, 2026
1 condition
1 sponsor
2 locations
NCT04092933
Perioperative Risk Calculator
N/A
Active, not recruiting
175,559 participants
Started: May 1, 2014 · Completed: Dec 31, 2024
1 condition
2 sponsors
0 locations
NCT02137005
Cerebral Palsy Adult Transition Longitudinal Study
N/A
Active, not recruiting
72 participants
Started: May 1, 2014 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT06079086
Evaluation of the Clinical Evolution of Breast Increase Using Prostheses
NA
Active, not recruiting
60 participants
Started: May 1, 2014 · Completed: May 30, 2024
2 conditions
1 sponsor
0 locations
NCT02124421
HOT: HIPEC in Ovarian Cancer as Initial Treatment
PHASE2
Active, not recruiting
32 participants
Started: Apr 30, 2014 · Completed: Apr 30, 2028
7 conditions
1 sponsor
1 location
NCT02270359
Research on Infarction With Open Arteries Using OCT and CMR
NA
Active, not recruiting
15 participants
Started: Apr 30, 2014 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT02077335
Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer
PHASE2
Active, not recruiting
50 participants
Started: Apr 30, 2014 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT02041936
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System
NA
Active, not recruiting
4 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02056769
CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage
NA
Active, not recruiting
41 participants
Started: Apr 30, 2014 · Completed: Jun 30, 2026
4 conditions
1 sponsor
1 location
NCT02104310
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
N/A
Active, not recruiting
25 participants
Started: Apr 30, 2014 · Completed: Mar 31, 2031
1 condition
2 sponsors
1 location
NCT02206360
Pancreatic Cancer Early Detection Program
N/A
Active, not recruiting
100 participants
Started: Apr 30, 2014 · Completed: Jun 30, 2024
11 conditions
1 sponsor
1 location
NCT02134054
Stavanger IBD Study - Cross Sectional
N/A
Active, not recruiting
210 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2024
1 condition
3 sponsors
1 location
NCT02087826
Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS
NA
Active, not recruiting
1,017 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2025
3 conditions
3 sponsors
1 location
NCT02115724
Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)
NA
Active, not recruiting
74 participants
Started: Apr 30, 2014 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
NCT05523856
New Treatment Modalities for Localized Prostate Cancer
N/A
Active, not recruiting
480 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2027
1 condition
15 sponsors
0 locations
NCT02050347
Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)
PHASE1
Active, not recruiting
7 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2030
3 conditions
3 sponsors
2 locations
NCT02123641
Physical Activity as Intervention Against Age-related Loss of Muscle Mass and Function
NA
Active, not recruiting
451 participants
Started: Apr 30, 2014 · Completed: Jun 30, 2028
4 conditions
3 sponsors
1 location
NCT02213497
Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
PHASE1
Active, not recruiting
30 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02106611
Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors
N/A
Active, not recruiting
133 participants
Started: Apr 30, 2014 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT01953900
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
PHASE1
Active, not recruiting
26 participants
Started: Apr 30, 2014 · Completed: Oct 31, 2034
2 conditions
4 sponsors
2 locations
NCT03301168
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
PHASE1/PHASE2
Active, not recruiting
120 participants
Started: Apr 30, 2014 · Completed: May 31, 2034
9 conditions
1 sponsor
10 locations
NCT01888601
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
N/A
Active, not recruiting
814 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2026
1 condition
2 sponsors
18 locations
NCT01915615
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
N/A
Active, not recruiting
2,750 participants
Started: Apr 30, 2014 · Completed: Jun 30, 2025
1 condition
3 sponsors
44 locations
NCT02170090
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
PHASE3
Active, not recruiting
789 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2025
2 conditions
5 sponsors
67 locations
NCT02015117
Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain Metastases
PHASE1
Active, not recruiting
10 participants
Started: Apr 28, 2014 · Completed: Oct 8, 2026
1 condition
1 sponsor
1 location
NCT03182335
Vasopressor SAT Study
N/A
Active, not recruiting
800 participants
Started: Apr 28, 2014 · Completed: Jun 30, 2026
3 conditions
1 sponsor
1 location
NCT02935400
Acute Porphyria Biomarkers for Disease Activity
N/A
Active, not recruiting
50 participants
Started: Apr 28, 2014 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT02068794
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
PHASE1/PHASE2
Active, not recruiting
34 participants
Started: Apr 25, 2014 · Completed: Dec 1, 2025
18 conditions
2 sponsors
1 location
NCT02032823
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
PHASE3
Active, not recruiting
1,837 participants
Started: Apr 22, 2014 · Completed: May 28, 2029
1 condition
7 sponsors
698 locations
NCT02105766
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
PHASE2
Active, not recruiting
56 participants
Started: Apr 21, 2014 · Completed: Dec 31, 2027
4 conditions
3 sponsors
1 location
NCT02135042
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
PHASE2/PHASE3
Active, not recruiting
685 participants
Started: Apr 21, 2014 · Completed: Feb 28, 2031
5 conditions
2 sponsors
215 locations
NCT01959698
Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
PHASE1
Active, not recruiting
29 participants
Started: Apr 17, 2014 · Completed: Dec 1, 2025
7 conditions
3 sponsors
1 location
NCT02122107
Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History
N/A
Active, not recruiting
499 participants
Started: Apr 8, 2014 · Completed: Apr 30, 2026
1 condition
3 sponsors
2 locations
NCT02299999
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
PHASE2
Active, not recruiting
1,460 participants
Started: Apr 7, 2014 · Completed: Dec 31, 2025
1 condition
3 sponsors
25 locations
NCT04214756
Methodist Acute Pancreatitis Protocol
N/A
Active, not recruiting
500 participants
Started: Apr 5, 2014 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT02106598
Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases
PHASE1/PHASE2
Active, not recruiting
67 participants
Started: Apr 3, 2014 · Completed: Apr 30, 2026
1 condition
1 sponsor
2 locations
NCT02023463
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
PHASE1
Active, not recruiting
25 participants
Started: Apr 2, 2014 · Completed: Jan 1, 2040
5 conditions
3 sponsors
1 location
NCT02118649
Enhancing Behavior and Brain Response to Visual Targets Using a Computer Game
NA
Active, not recruiting
100 participants
Started: Apr 1, 2014 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT04812353
Foot and Ankle Arthrodesis or Osteotomy With Io-Fix Type Fixation
NA
Active, not recruiting
208 participants
Started: Apr 1, 2014 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT02076113
Cervical Spondylotic Myelopathy Surgical Trial
NA
Active, not recruiting
269 participants
Started: Apr 1, 2014 · Completed: Dec 30, 2025
1 condition
2 sponsors
16 locations
NCT02096159
Prophylactic Antibiotics or Placebo After Hypospadias Repair
NA
Active, not recruiting
93 participants
Started: Mar 31, 2014 · Completed: Aug 31, 2025
1 condition
2 sponsors
2 locations
NCT02038140
Zimmer Trabecular Metal Total Ankle PMCF
NA
Active, not recruiting
120 participants
Started: Mar 31, 2014 · Completed: Mar 31, 2027
3 conditions
1 sponsor
11 locations
NCT02091245
Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML
PHASE1
Active, not recruiting
16 participants
Started: Mar 31, 2014 · Completed: Dec 31, 2025
9 conditions
3 sponsors
10 locations
NCT02149030
Effectiveness of Cervical Screening in HPV Vaccinated Women
NA
Active, not recruiting
6,958 participants
Started: Mar 31, 2014 · Completed: Jan 31, 2025
1 condition
4 sponsors
31 locations
NCT01903330
ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
PHASE2
Active, not recruiting
84 participants
Started: Mar 31, 2014 · Completed: Jun 30, 2026
2 conditions
2 sponsors
3 locations
NCT02446405
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
PHASE3
Active, not recruiting
1,125 participants
Started: Mar 31, 2014 · Completed: Jun 30, 2027
1 condition
5 sponsors
82 locations
Previous
1
More pages
398
399
400
401
402
403
404
More pages
431
Next